Ozempic and other GLP-1s could have a surprising effect on the progression of cancer.

Medicare has expanded access to GLP-1 weight-loss medications. These drugs may also help treat addiction. Primary care ...

Israel: An analysis of electronic health record data found that adults with type 2 diabetes who used GLP-1 receptor agonists ...

Psoriasis and psoriatic arthritis (PsA) are chronic, immune-mediated inflammatory diseases associated with several shared common comorbidities, of which obesity is one of the most prevalent. A complex ...

Following the US FDA approval of GLP-1 RA drugs for weight loss, exposures reported to US poison centers increased.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and ...

GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is ...

If you’re considering taking a GLP-1 (glucagon-like peptide-1) receptor agonist for weight loss, here’s what to know about the long-term benefits and risks, along with insights from physicians. GLP-1 ...

GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...

GLP-1 receptor agonists may lower the likelihood of psychiatric treatment intensification in patients with type 2 diabetes and depression.

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 agonists like Ozempic are primarily used to treat type 2 diabetes. Its popularity has even influenced wholesale retailer ...

Two-thirds of websites did not require clinician interaction before a prescription ...